Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 541 AL 555

The neglected role of histamine in Alzheimer's disease

Naddafi F, Mirshafiey A.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):327-36. doi: 10.1177/1533317513488925. Epub 2013 May 15.

Spontaneous and induced nontransgenic animal models of AD: modeling AD using combinatorial approach

Kaushal A, Wani WY, Anand R, Gill KD.

Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):318-26. doi: 10.1177/1533317513488914. Epub 2013 May 17.

Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy

Wang J, Yu JT, Tan MS, Jiang T, Tan L.

Ageing Res Rev. 2013 Sep;12(4):1024-41. doi: 10.1016/j.arr.2013.05.003. Epub 2013 May 17.

The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms

Lương Kv, Nguyen LT.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):427-39. doi: 10.1177/1533317513488924. Epub 2013 May 20.

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment

Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9523-8. doi: 10.1073/pnas.1301816110. Epub 2013 May 20.

Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches

Fuster-Matanzo A, Llorens-Martín M, Hernández F, Avila J.

Mediators Inflamm. 2013;2013:260925. doi: 10.1155/2013/260925. Epub 2013 Apr 3.

Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion

Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA.

Oxid Med Cell Longev. 2013;2013:962984. doi: 10.1155/2013/962984. Epub 2013 Apr 3.

[Vascular factors in the pathogenesis of Alzheimer's disease]

Lange-Asschenfeldt C.

Nervenarzt. 2013 Jun;84(6):732-7. doi: 10.1007/s00115-013-3800-1.

Do angiotensin receptor blockers prevent Alzheimer's disease?

Hajjar I, Rodgers K.

Curr Opin Cardiol. 2013 Jul;28(4):417-25. doi: 10.1097/HCO.0b013e3283620745.

The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease

Kljajevic V, Meyer P, Holzmann C, Dyrba M, Kasper E, Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel S; EDSD study group.

Alzheimers Dement. 2014 May;10(3):401-4. doi: 10.1016/j.jalz.2013.02.008. Epub 2013 May 21.

When previously expressed wishes conflict with best interests

Smith AK, Lo B, Sudore R.

JAMA Intern Med. 2013 Jul 8;173(13):1241-5. doi: 10.1001/jamainternmed.2013.6053.

Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease

Bignante EA, Heredia F, Morfini G, Lorenzo A.

Neurobiol Aging. 2013 Nov;34(11):2525-37. doi: 10.1016/j.neurobiolaging.2013.04.021. Epub 2013 May 25.

[Research progress of transgenic Drosophila model of Alzheimer disease]

Tan Y, Ji YB, Zhao J.

Yao Xue Xue Bao. 2013 Mar;48(3):333-6.

Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease

Singh M, Simpkins JW, Simpkins JW, Bimonte-Nelson HA, Bimonte-Nelson HA, Brinton RD, Brinton RD.

Brain Res. 2013 Jun 13;1514:1-2. doi: 10.1016/j.brainres.2013.04.044.

Neuronal autophagy: self-eating or self-cannibalism in Alzheimer's disease

Ułamek-Kozioł M, Furmaga-Jabłońska W, Januszewski S, Brzozowska J, Sciślewska M, Jabłoński M, Pluta R.

Neurochem Res. 2013 Sep;38(9):1769-73. doi: 10.1007/s11064-013-1082-4. Epub 2013 Jun 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias